The beta2 subfamily of integrins, which includes alphaMbeta2, controls the participation of leukocytes in biological settings. A number of specific leukocyte responses are regulated by alphaMbeta2, including the respiratory burst, homotypic aggregation, phagocytosis, migration, apoptosis, tumor surveillance, and ischemia-reperfusion injury. These responses depend upon the capacity of alphaMbeta2, to function as a receptor for an extremely broad spectrum of ligands. The mechanism by which alphaMbeta2 interacts with structurally diverse ligands to mediate the cellular responses of adhesion, migration and activation is the central focus of this application. Preliminary data developed in this application indicate that four representative ligands, iC3b, NIF, the P2 peptide of fibrinogen and C. albicans, not only interact with the I-domain in the alphaM subunit but also utilized the same five small segments on the cation-binding MIDAS face for ligand engagement. The hypothesis to be tested in Aim I is that different contact residues within these five segments contact these structurally-unrelated ligands. This mosaic model of ligand binding to alphaMbeta2 will be tested by systematic mutagenesis involving not only loss but also gain-in-function strategies. Preliminary data in the application indicate that P2, a 19 amino acid peptide corresponding to residues 377-395 of the gamma-chain of fibrinogen, contains all the information needed to support alphaMbeta2 -dependent cell adhesion, migration and activation.
In Aim 2, the role of the individual amino acids within P2 and within alphaMbeta2 in eliciting these responses will be dissected. The hypothesis to be tested is that, in order to generate the differential intracellular signals required to elicit these alphaMbeta2 -dependent cellular responses, different contact residues in the peptide and in the receptor must interact.
Aim 3 focuses upon the interaction of the major opportunistic pathogen C. albicans with alphaMbeta2. Evidence for release of a soluble ligand, CASL, from the fungus, which interacts with alphaMbeta2 to induce cell adhesion and migration, has been developed. CASL will be isolated, its sequence determined, and its role in controlling the virulence of C. albicans will be established in vitro and in vivo. Overall, the proposed studies have the potential to provide fundamental insights into the functioning of a receptor, alphaMbeta2, which plays a major role in controlling leukocyte responses. The insights gained from these studies are likely to extend to other leukocyte integrins as well. Specific therapeutic targets for controlling the pathogenesis associated with insufficient or overly exuberant alphaMbeta2 -mediated responses, ranging from inflammatory responses to fungal infections, will also be identified through these studies.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
7R01HL066197-04
Application #
6684179
Study Section
Hematology Subcommittee 2 (HEM)
Program Officer
Ganguly, Pankaj
Project Start
2000-12-15
Project End
2005-11-30
Budget Start
2003-12-01
Budget End
2005-11-30
Support Year
4
Fiscal Year
2004
Total Cost
$344,250
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Other Basic Sciences
Type
Schools of Medicine
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Soloviev, Dmitry A; Fonzi, William A; Sentandreu, Rafael et al. (2007) Identification of pH-regulated antigen 1 released from Candida albicans as the major ligand for leukocyte integrin alphaMbeta2. J Immunol 178:2038-46
Ustinov, Valentin A; Plow, Edward F (2005) Identity of the amino acid residues involved in C3bi binding to the I-domain supports a mosaic model to explain the broad ligand repertoire of integrin alpha M beta 2. Biochemistry 44:4357-64
Solovjov, Dmitry A; Pluskota, Elzbieta; Plow, Edward F (2005) Distinct roles for the alpha and beta subunits in the functions of integrin alphaMbeta2. J Biol Chem 280:1336-45
Wang, Yunmei; Sakuma, Masashi; Chen, Zhiping et al. (2005) Leukocyte engagement of platelet glycoprotein Ibalpha via the integrin Mac-1 is critical for the biological response to vascular injury. Circulation 112:2993-3000
Pluskota, Elzbieta; Stenina, Olga I; Krukovets, Irene et al. (2005) Mechanism and effect of thrombospondin-4 polymorphisms on neutrophil function. Blood 106:3970-8
Flick, Matthew J; Du, XinLi; Witte, David P et al. (2004) Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest 113:1596-606
Pluskota, Elzbieta; Soloviev, Dmitry A; Bdeir, Khalil et al. (2004) Integrin alphaMbeta2 orchestrates and accelerates plasminogen activation and fibrinolysis by neutrophils. J Biol Chem 279:18063-72
Ma, Yan-Qing; Plow, Edward F; Geng, Jian-Guo (2004) P-selectin binding to P-selectin glycoprotein ligand-1 induces an intermediate state of alphaMbeta2 activation and acts cooperatively with extracellular stimuli to support maximal adhesion of human neutrophils. Blood 104:2549-56
Ehlers, Raila; Ustinov, Valentin; Chen, Zhiping et al. (2003) Targeting platelet-leukocyte interactions: identification of the integrin Mac-1 binding site for the platelet counter receptor glycoprotein Ibalpha. J Exp Med 198:1077-88
Pluskota, Elzbieta; Soloviev, Dmitry A; Plow, Edward F (2003) Convergence of the adhesive and fibrinolytic systems: recognition of urokinase by integrin alpha Mbeta 2 as well as by the urokinase receptor regulates cell adhesion and migration. Blood 101:1582-90

Showing the most recent 10 out of 12 publications